Eyenovia, inc. (EYEN)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17
Operating Expenses:
Research and development

3,634

3,324

3,201

3,568

4,008

4,125

2,487

2,412

2,094

1,583

570

751

910

General and administrative

1,836

1,964

1,489

1,809

1,942

2,058

1,832

908

1,337

579

314

224

195

Total Operating Expenses

5,471

5,288

4,690

5,377

5,951

6,183

4,320

3,320

3,431

2,163

885

976

1,106

Loss From Operations

-5,471

-5,288

-4,690

-5,377

-5,951

-6,183

-4,320

-3,320

-3,431

-2,163

-885

-976

-1,106

Other Income:
Interest expense

3

-

-

-

-

-

-

-

-

-

-

-

-

Interest income

23

47

41

43

19

0

-0

1

2

-

0

-

-

Interest income

-

-

-

-

-

-

-

-

-

-

-

0

0

Net Loss

-5,450

-5,241

-4,649

-5,333

-5,932

-6,183

-4,321

-3,319

-3,429

-2,162

-884

-976

-1,106

Net Loss Per Share
- Basic and Diluted

-0.31

-0.24

-0.29

-0.44

-0.50

-0.61

-0.43

-0.33

-0.45

-1.17

-0.10

-0.43

-0.49

Weighted Average Number of Common Shares Outstanding
- Basic and Diluted

17,308

17,173

16,270

12,034

11,919

10,315

10,030

9,998

7,561

-3,669

8,514

2,266

2,266